Marah Hehemann, MD
Urology · Seattle, WANPI 1396011193
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Coloplast accounts for 60.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $70,773 and has fallen 85.3% since, to $10,435 in 2025. Among urology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 443 payments — averaging $480.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$128K
- Boston Scientific$62K
- Endo Pharmaceuticals Inc.$13K
- Endo USA, Inc.$10K
- Procept Biorobotics Corporation$102
- Innovation Technologies Inc$23
What the payments were for
- Consulting fees$120,45157%
- Speaking & faculty fees$48,61023%
- Grants$1,0000%
- Travel & lodging$30,09514%
- Food & beverage$12,6446%
- Education$1150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 185 | $128,157 |
| Boston Scientific | 233 | $61,723 |
| Endo Pharmaceuticals Inc. | 16 | $13,005 |
| Endo USA, Inc. | 7 | $9,905 |
| Procept Biorobotics Corporation | 1 | $102 |
| Innovation Technologies Inc | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$108,103
- XIAFLEX$22,493
- GENERAL ERECTILE DYSFUNCTION$11,853
- TACTRA$10,800
- ALTIS$10,104
- AMS$5,172
- AMS 700 CXR RTE KIT$4,513
- VIRTUE$4,250
- AMS 700$1,840
- ADVANCE$1,065
- SPEEDICATH$1,000
- GENERAL - THERAPIES$619
- GENESIS$240
- AVEED$148
- AquaBeam Robotic System$102
How this compares
$212,915 in reported general payments places this provider in the 95th percentile of 274 urology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 13 | $18,193 |
| Trospium Chloride ErTrospium Chloride | 11 | $1,320 |
| Tamsulosin Hcl | 24 | $309 |
| Finasteride | 12 | $148 |
Paid to pharmacies, not to this prescriber.
Other urology in Seattle
- James PorterSeattle$471K
- Thomas WalshSeattle$186K
- Alvaro LucioniSeattle$148K
- Una LeeSeattle$116K
- George SchadeSeattle$78K
- Vi NguyenSeattle$53K
- Rogerio HuangSeattle$45K
- Cristopher GarlitzSeattle$45K
- Sarah PsutkaSeattle$40K
- Daniel LinSeattle$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.